Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Synthetic hair implants can cause severe scalp problems and removing them improves conditions; natural hair transplants are safer and more effective.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The gel effectively reduced folliculitis symptoms and was safe to use.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Blocking IL-8 can reduce skin rashes from cancer treatment.